Adma Biologics Stock Market Value
| ADMA Stock | USD 16.73 0.86 4.89% |
| Symbol | ADMA |
ADMA Biologics Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ADMA Biologics. If investors know ADMA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ADMA Biologics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.414 | Earnings Share 0.84 | Revenue Per Share | Quarterly Revenue Growth 0.402 | Return On Assets |
The market value of ADMA Biologics is measured differently than its book value, which is the value of ADMA that is recorded on the company's balance sheet. Investors also form their own opinion of ADMA Biologics' value that differs from its market value or its book value, called intrinsic value, which is ADMA Biologics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ADMA Biologics' market value can be influenced by many factors that don't directly affect ADMA Biologics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ADMA Biologics' value and its price as these two are different measures arrived at by different means. Investors typically determine if ADMA Biologics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ADMA Biologics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
ADMA Biologics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to ADMA Biologics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of ADMA Biologics.
| 04/20/2025 |
| 07/19/2025 |
If you would invest 0.00 in ADMA Biologics on April 20, 2025 and sell it all today you would earn a total of 0.00 from holding ADMA Biologics or generate 0.0% return on investment in ADMA Biologics over 90 days. ADMA Biologics is related to or competes with Allogene Therapeutics, Anixa Biosciences, Akero Therapeutics, Ardelyx, Sonnet Biotherapeutics, Arbutus Biopharma, and Aldeyra. ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-... More
ADMA Biologics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure ADMA Biologics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess ADMA Biologics upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.12) | |||
| Maximum Drawdown | 22.33 | |||
| Value At Risk | (5.75) | |||
| Potential Upside | 4.84 |
ADMA Biologics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for ADMA Biologics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as ADMA Biologics' standard deviation. In reality, there are many statistical measures that can use ADMA Biologics historical prices to predict the future ADMA Biologics' volatility.| Risk Adjusted Performance | (0.07) | |||
| Jensen Alpha | (0.50) | |||
| Total Risk Alpha | (0.78) | |||
| Treynor Ratio | (0.18) |
ADMA Biologics Backtested Returns
ADMA Biologics secures Sharpe Ratio (or Efficiency) of -0.0612, which signifies that the company had a -0.0612 % return per unit of return volatility over the last 3 months. ADMA Biologics exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm ADMA Biologics' Coefficient Of Variation of (1,255), mean deviation of 2.49, and Risk Adjusted Performance of (0.07) to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 1.63, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, ADMA Biologics will likely underperform. At this point, ADMA Biologics has a negative expected return of -0.2%. Please make sure to confirm ADMA Biologics' potential upside, daily balance of power, and the relationship between the maximum drawdown and kurtosis , to decide if ADMA Biologics performance from the past will be repeated in the future.
Auto-correlation | 0.57 |
Modest predictability
ADMA Biologics has modest predictability. Overlapping area represents the amount of predictability between ADMA Biologics time series from 20th of April 2025 to 4th of June 2025 and 4th of June 2025 to 19th of July 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of ADMA Biologics price movement. The serial correlation of 0.57 indicates that roughly 57.0% of current ADMA Biologics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.57 | |
| Spearman Rank Test | 0.22 | |
| Residual Average | 0.0 | |
| Price Variance | 1.82 |
ADMA Biologics lagged returns against current returns
Autocorrelation, which is ADMA Biologics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting ADMA Biologics' stock expected returns. We can calculate the autocorrelation of ADMA Biologics returns to help us make a trade decision. For example, suppose you find that ADMA Biologics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
ADMA Biologics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If ADMA Biologics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if ADMA Biologics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in ADMA Biologics stock over time.
Current vs Lagged Prices |
| Timeline |
ADMA Biologics Lagged Returns
When evaluating ADMA Biologics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of ADMA Biologics stock have on its future price. ADMA Biologics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, ADMA Biologics autocorrelation shows the relationship between ADMA Biologics stock current value and its past values and can show if there is a momentum factor associated with investing in ADMA Biologics.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether ADMA Biologics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of ADMA Biologics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Adma Biologics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Adma Biologics Stock:Check out ADMA Biologics Correlation, ADMA Biologics Volatility and ADMA Biologics Alpha and Beta module to complement your research on ADMA Biologics. For information on how to trade ADMA Stock refer to our How to Trade ADMA Stock guide.You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
ADMA Biologics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.